A Grunenthal First: Establishing A US Presence With A Tailored Marketing Strategy

 
• By John Davis

Germany's pain-focused specialty pharmaceutical firm is adding America to its commercial reach, through acquiring New York's Averitas Pharma to jumpstart its push to commercialize products on its own account, via a niche approach.  

Broken arm
Complex regional pain syndromes often involve injured extremities. • Source: Shutterstock

More from Deals

More from Business